Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

62.27   -0.42 (-0.67%) 09-29 00:32
Open: 63.21 Pre. Close: 62.69
High: 63.98 Low: 61.95
Volume: 350,077 Market Cap: 3,717M
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. The company is headquartered in New Haven, Connecticut and currently employs 63 full-time employees. The firm is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. The firm's glutamate platform includes three clinical-stage product candidates being developed for the treatment of various neurological indications: trigriluzole for the treatment of obsessive-compulsive disorder (OCD), spinocerebellar ataxia (SCA) and Alzheimer's disease; BHV-0223 for the treatment of amyotrophic lateral sclerosis (ALS), and BHV-5000 for the treatment of neurological and psychiatric illnesses such as Rett syndrome, neuropathic pain and treatment-resistant depression. BHV-0223 is developing for the treatment of ALS, a neurodegenerative disease that affects nerve cells in the brain and spinal cord.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 64.074 - 64.397 64.397 - 64.663
Low: 61.233 - 61.57 61.57 - 61.848
Close: 61.796 - 62.325 62.325 - 62.759

Technical analysis

as of: 2020-09-28 4:30:20 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 76.15     One year: 88.95
Support: Support1: 60.56    Support2: 57.70
Resistance: Resistance1: 65.20    Resistance2: 76.15
Pivot: 62.07
Moving Average: MA(5): 62.51     MA(20): 62.08
MA(100): 64.21     MA(250): 53.53
MACD: MACD(12,26): -0.25     Signal(9): -0.49
Stochastic oscillator: %K(14,3): 62.80     %D(3): 64.86
RSI: RSI(14): 49.33
52-week: High: 78.75  Low: 26.56  Change(%): 50.4
Average Vol(K): 3-Month: 50987  10-Days: 58171

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
BHVN has closed below upper band by 45.6%. Bollinger Bands are 55.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to BHVN's normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 28 Sep 2020
BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region - PRNewswire

Sat, 26 Sep 2020
Investor confidence returns after Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) share prices gain $0.44 - Marketing Sentinel

Thu, 24 Sep 2020
Should Biohaven Pharmaceutical Holding Co Ltd (BHVN) Stock be in Your Portfolio? - InvestorsObserver

Thu, 24 Sep 2020
Daily High to Daily Low: Is It Safe to Buy Biohaven Pharmaceutical Holding Company Ltd. (BHVN)? - newsheater.com

Wed, 23 Sep 2020
Should You Buy Biohaven Pharmaceutical Holding Co Ltd (BHVN) Stock After it Has Fallen 0.03% in a Week? - InvestorsObserver

Wed, 23 Sep 2020
John W. Childs Buys 3,322 Shares of Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) Stock - MarketBeat

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 58
Shares Float (M) 52
% Held by Insiders 13.91
% Held by Institutions 97.21
Shares Short (K) 9,570
Shares Short P. Month (K) 9,320

Stock Financials

EPS -11.100
EPS Est This Year -5.450
EPS Est Next Year -4.390
Book Value (p.s.) -0.600
Profit Margin
Operating Margin -4949.62
Return on Assets (ttm) -73.3
Return on Equity (ttm) -805.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share 0.186
EBITDA (p.s.) -9.187
Qtrly Earnings Growth
Operating Cash Flow (M) -497
Levered Free Cash Flow (M) -341

Stock Valuations

PE Ratio -5.61
PEG Ratio
Price to Book value -103.82
Price to Sales 334.64
Price to Cash Flow -7.30

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.